2015
DOI: 10.1016/j.actpsy.2015.02.001
|View full text |Cite
|
Sign up to set email alerts
|

Dopaminergic medication alters auditory distractor processing in Parkinson's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
35
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 24 publications
(36 citation statements)
references
References 79 publications
1
35
0
Order By: Relevance
“…Some studies indicated the positive role of dopaminergic treatment in the auditory paradigms. Georgiev et al (2015) showed that the effect of medication on P3a response was observed only during auditory stimulations but not during visual stimulations. Geiser and Kaelin-Lang (2011) showed that auditory pulse perception was preserved in PD patients during the early stages of the disease.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Some studies indicated the positive role of dopaminergic treatment in the auditory paradigms. Georgiev et al (2015) showed that the effect of medication on P3a response was observed only during auditory stimulations but not during visual stimulations. Geiser and Kaelin-Lang (2011) showed that auditory pulse perception was preserved in PD patients during the early stages of the disease.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore it was not possible to control the effects of medication. The effect of L-Dopa on spontaneous EEG, ERPs ( Georgiev et al, 2015 ) and as well as in different frequency bands were reported ( Huebl et al, 2014 ). However, little is known about the effect of medication on event related oscillations in PD patients with different cognitive states, and it remains an essential question.…”
Section: Discussionmentioning
confidence: 99%
“…Georgiev et al, (2015) have shown that auditory processing is altered in PD patients. PD patients, tested with medication manipulation, were compared to healthy agematched controls and have displayed deficits in distractor processing in the auditory modality (Georgiev et al, 2015). Moreover, PD patients tested on medication have shown deficiencies in neural entrainment, with an associated deficit between auditory to motor entrainment (te Woerd et al., 2017a, 2017b, 2015).…”
Section: Discussionmentioning
confidence: 99%
“…P3a amplitude has been found to be attenuated in PD in some studies (Li et al, 2005;Solís-Vivanco et al, 2011Tsuchiya et al, 2000;Wang et al, 1999Wang et al, , 2000, but not in others (Bocquillon et al, 2012;Gaudreault et al, 2013;Georgiev et al, 2015;Hozumi et al, 2000;Pirtošek et al, 2001;Tachibana et al, 1992;Toda et al, 1993;Zeng et al, 2002 et al, 2000). In addition, smaller P3a amplitudes obtained from threestimulus oddball tasks have been associated with more efficient performance in more demanding tasks (Lange et al, 2015).…”
Section: P3b In Pd: Conclusion and Future Directionsmentioning
confidence: 99%
“…Hence, medication effects were always confounded with potential effects of learning, fatigue or habituation. In a recent study that controlled for these factors (Georgiev et al, 2015), no differences in P3b latency have been found as a function of PD patients' dopaminergic status (see also Vieregge et al, 1994). Second, it has to be noted that sample sizes were considerably smaller in the studies reporting a levodopa-associated decrease in P3b latency (mean N = 14.8) than in the studies reporting no such effect (mean N = 23.5; pone-tailed t-test = 0.03), thus challenging the reliability of the proposed levodopa effect.…”
Section: P3b and Dopaminergic Medication In Pdmentioning
confidence: 99%